24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Advent
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:12
OpenAI, Nvidia, and the bubble debate: Lessons from 30 years of tech surges
13:42
The Elephant appoints Oded Harniv as Chief Information Officer
13:31
CTech's Book Review: The art of building genuine human relationships
12:06
The return of the pay raise: Why companies are betting on money over perks
More stories
Buzz
Most popular
Daily
Weekly
1
After $5B valuation, cyber unicorn Island doubles down on Israel with new R&D center
2
The 9-to-9 workday is back and it’s spreading beyond Silicon Valley
3
He built a billion-dollar tech empire. Now he’s bankrupt and still believes it’s temporary.
4
Ilya Sutskever breaks silence on OpenAI departure: “I had a big new vision”
5
Cyber unicorn Axonius cuts more than 10% of staff amid restructuring
More news
Advent
5 stories about Advent
Advent bets on cloud transition with $2.5 billion Sapiens acquisition
14.08.25
|
Almog Azar
Insurtech’s U.S. market ambitions hinge on private equity’s deep network.
Advent to acquire Sapiens for $2.5 billion, ending its public market run
13.08.25
|
Almog Azar, CTech
Insurance software maker to go private at 64% premium as private equity bets on SaaS and AI transformation.
BigPanda enters unicorn club with $190 million funding at $1.2 billion valuation
12.01.22
|
Meir Orbach
The IT management company raised the sum in two rounds over a month-and-a-half in late 2021
Advent Delays $1.9 Billion ForeScout Acquisition
19.05.20
|
Hagar Ravet
The companies are in ongoing discussions concerning the timing and terms of completion, but, according to ForeScout, there can be no assurance that they could reach an agreement
Cerberus, Advent Eye Teva's European Assets, Report Says
15.08.17
|
Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report